Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP736622.RATKvF86Y8X28_uDLSyWX5I4oYwfFUA_zC22Krt19uSmY130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736622.RATKvF86Y8X28_uDLSyWX5I4oYwfFUA_zC22Krt19uSmY130_provenance.
• NP736638.RASPO-XMIcTe8IxC8B1a3TJHijr7WuziwyVHl0rZWdH8k130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736638.RASPO-XMIcTe8IxC8B1a3TJHijr7WuziwyVHl0rZWdH8k130_provenance.
• NP736718.RAf6KHN_Vf60kTvTEQnvQN5jXQiBysST446kVAqWuY1PE130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736718.RAf6KHN_Vf60kTvTEQnvQN5jXQiBysST446kVAqWuY1PE130_provenance.
• NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756713.RAcjA6JG832KR-KtMXRiBDJqgKHfytXLUMR6HvEmEZbzA130_provenance.
• assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP376129.RAe4rE9bRrau5BL8FpWxATdDYlfFr86Q7TdeUaE7aO1ao130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376129.RAe4rE9bRrau5BL8FpWxATdDYlfFr86Q7TdeUaE7aO1ao130_provenance.
• NP376134.RAUHyX5uJdejJ-TvQ66hMxNeTcDRCCd2OkufAeb2RcVj8130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376134.RAUHyX5uJdejJ-TvQ66hMxNeTcDRCCd2OkufAeb2RcVj8130_provenance.
• NP376138.RAXSCj55ILPwMLMqmj8N0fcE66RhIqyFKDd0GBOtmFRMM130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376138.RAXSCj55ILPwMLMqmj8N0fcE66RhIqyFKDd0GBOtmFRMM130_provenance.
• NP736785.RADs5kYqKRi0D2KJJYBLOmTT7NRDVXZCqUJeEkjfiSYRU130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736785.RADs5kYqKRi0D2KJJYBLOmTT7NRDVXZCqUJeEkjfiSYRU130_provenance.
• NP736636.RAlUGE5btUh5Tk1xzKVoQNTn3H18Qk6UM2aj4WA-z-4K0130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736636.RAlUGE5btUh5Tk1xzKVoQNTn3H18Qk6UM2aj4WA-z-4K0130_provenance.
• NP756750.RAgAfOizCLmEhrjeG9ar8MeDhPGJK19w-F0at3k6olzNU130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756750.RAgAfOizCLmEhrjeG9ar8MeDhPGJK19w-F0at3k6olzNU130_provenance.
• NP376128.RAAVGoIjJ_sCkm9PxyyzdYfUw9sUDAoipuCiyrj13z9zY130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376128.RAAVGoIjJ_sCkm9PxyyzdYfUw9sUDAoipuCiyrj13z9zY130_provenance.
• NP756759.RAx7cED4FWgMh9rpOc31R0VEsNn88QpBtyIhICGzx2WDY130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756759.RAx7cED4FWgMh9rpOc31R0VEsNn88QpBtyIhICGzx2WDY130_provenance.
• NP756970.RA-SGyE-5-0XtamQAeAse43f7EUPxA_QeZ21UbeJZKVDU130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756970.RA-SGyE-5-0XtamQAeAse43f7EUPxA_QeZ21UbeJZKVDU130_provenance.
• NP376126.RAJXwYNTXTvERqBm6wTti7k45B3MT_p2TqYrQg0aTBovc130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376126.RAJXwYNTXTvERqBm6wTti7k45B3MT_p2TqYrQg0aTBovc130_provenance.
• NP376127.RAJfYt8gmvyrPLSsgedDE0wQmm7YvvnWoKt_hlZiim1n0130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376127.RAJfYt8gmvyrPLSsgedDE0wQmm7YvvnWoKt_hlZiim1n0130_provenance.
• NP376136.RAPA2WsUn7-paNIclhhOj7IPMybHBBSSZv9jRqO9UfXCY130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376136.RAPA2WsUn7-paNIclhhOj7IPMybHBBSSZv9jRqO9UfXCY130_provenance.
• NP736737.RA2hGVxJDc7kZ4AgRu3ISZ1ra-K9MXHe9_tNc5BWtdRfw130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736737.RA2hGVxJDc7kZ4AgRu3ISZ1ra-K9MXHe9_tNc5BWtdRfw130_provenance.
• NP736838.RA9LpvV0R6nrdPu3vbAdV2nU17sP0HY13jX6l9OVp2QGQ130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736838.RA9LpvV0R6nrdPu3vbAdV2nU17sP0HY13jX6l9OVp2QGQ130_provenance.
• NP376132.RA2kPP_hlOxe30pvnFkSyAUiPhybYy5StGkvnpAD0tLr8130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376132.RA2kPP_hlOxe30pvnFkSyAUiPhybYy5StGkvnpAD0tLr8130_provenance.
• NP376133.RA9Pnykp1wv2-qE0rCkh0R0Yzxum0HxpgmNra2qoYz78k130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376133.RA9Pnykp1wv2-qE0rCkh0R0Yzxum0HxpgmNra2qoYz78k130_provenance.
• NP376137.RA7uDs08CDPRr8mIf7LYRGi5yRyx196jhFqB9B4LKAWbA130_assertion description "[TPO transcripts were detected in 7/10 (70%) patients with known metastases of thyroid cancer and in 39 of 110 (36%) patients without metastases (P<0.05), in 15/44 (34%) patients with goitre, in 17/41 (41%) cases with GD and in 4/54 (7.4%) subjects in the control group (P<0.05, controls vs all patients with thyroid disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376137.RA7uDs08CDPRr8mIf7LYRGi5yRyx196jhFqB9B4LKAWbA130_provenance.